Investors
Share price
{{priceData.date}} {{priceData.time}}
{{'2025-03-29T14:33:58Z' | dateFormatFilter}}
Ozempic® (once-weekly semaglutide 1.0 mg) shown to improve walking distance and quality of life in adults with type 2 diabetes and peripheral artery disease (PAD) at ACC 2025
Read more
{{'2025-03-27T15:17:09Z' | dateFormatFilter}}
Resolutions from the Annual General Meeting of Novo Nordisk A/S
Read more
{{'2025-03-24T10:02:10Z' | dateFormatFilter}}
The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
Read more
Here are our current job openings. If there is not a job you are looking for, you are welcome to create a job agent or a candidate profile.